No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs561911089 |
chr7:33169613-33169614 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs529087676 |
chr7:33169644-33169645 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs1468797 |
chr7:33169660-33169661 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
4 |
rs79503896 |
chr7:33169670-33169671 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs539403348 |
chr7:33169725-33169726 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs528712776 |
chr7:33169746-33169747 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs551379434 |
chr7:33169770-33169771 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs187411516 |
chr7:33169776-33169777 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs533107422 |
chr7:33169820-33169821 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs538533135 |
chr7:33169834-33169835 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs367580425 |
chr7:33169851-33169852 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs115819560 |
chr7:33169860-33169861 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs138980339 |
chr7:33169918-33169919 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs192208478 |
chr7:33169938-33169939 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs554206992 |
chr7:33169980-33169981 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs572433106 |
chr7:33169997-33169998 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs545922345 |
chr7:33170042-33170043 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs369355769 |
chr7:33170047-33170048 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs562339521 |
chr7:33170066-33170067 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs184744333 |
chr7:33170068-33170069 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs551356916 |
chr7:33170094-33170095 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs1569239 |
chr7:33170104-33170105 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs543272963 |
chr7:33170125-33170126 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs561838247 |
chr7:33170134-33170135 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs529055658 |
chr7:33170160-33170161 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs189478477 |
chr7:33170166-33170167 |
Flanking Active TSS Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs559530856 |
chr7:33170236-33170237 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs376200718 |
chr7:33170306-33170307 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs533035839 |
chr7:33170317-33170318 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs77901428 |
chr7:33170321-33170322 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs567096206 |
chr7:33170347-33170348 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs150570189 |
chr7:33170348-33170349 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs534013721 |
chr7:33170358-33170359 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs551544849 |
chr7:33170361-33170362 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs569657948 |
chr7:33170411-33170412 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs530526584 |
chr7:33170442-33170443 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs193149028 |
chr7:33170531-33170532 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs34922240 |
chr7:33170548-33170549 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs555710967 |
chr7:33170549-33170550 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs567813985 |
chr7:33170557-33170558 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs115180620 |
chr7:33170593-33170594 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs554052022 |
chr7:33170603-33170604 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs5883385 |
chr7:33170630-33170631 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs184430464 |
chr7:33170636-33170637 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs1548880 |
chr7:33170658-33170659 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs557841036 |
chr7:33170741-33170742 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs569732348 |
chr7:33170768-33170769 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs189304534 |
chr7:33170798-33170799 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs139421307 |
chr7:33170808-33170809 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs113416823 |
chr7:33170817-33170818 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|